These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23275831)

  • 41. RhoA- and PKC-alpha-mediated phosphorylation of MYPT and its association with HSP27 in colonic smooth muscle cells.
    Patil SB; Bitar KN
    Am J Physiol Gastrointest Liver Physiol; 2006 Jan; 290(1):G83-95. PubMed ID: 16179599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclic HIV protease inhibitors: design and synthesis of orally bioavailable, pyrazole P2/P2' cyclic ureas with improved potency.
    Han Q; Chang CH; Li R; Ru Y; Jadhav PK; Lam PY
    J Med Chem; 1998 Jun; 41(12):2019-28. PubMed ID: 9622543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery of thieno[2,3-d]pyrimidin-4(3H)-one derivatives as a new class of ROCK inhibitors.
    Miao Z; Sun YM; Zhao LY; Li YS; Wang YF; Nan JS; Qiao ZE; Li LL; Yang SY
    Bioorg Med Chem Lett; 2020 Mar; 30(6):126966. PubMed ID: 32001136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery of first-in-class multi-target adenosine A
    Ceni C; Catarzi D; Varano F; Ben DD; Marucci G; Buccioni M; Volpini R; Angeli A; Nocentini A; Gratteri P; Supuran CT; Colotta V
    Eur J Med Chem; 2020 Sep; 201():112478. PubMed ID: 32659606
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure-based design, synthesis, and biological evaluation of conformationally restricted novel 2-alkylthio-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Mai A; Sbardella G; Artico M; Ragno R; Massa S; Novellino E; Greco G; Lavecchia A; Musiu C; La Colla M; Murgioni C; La Colla P; Loddo R
    J Med Chem; 2001 Aug; 44(16):2544-54. PubMed ID: 11472208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 2,3,5-Trisubstituted pyridines as selective AKT inhibitors-Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity.
    Lin H; Yamashita DS; Zeng J; Xie R; Wang W; Nidarmarthy S; Luengo JI; Rhodes N; Knick VB; Choudhry AE; Lai Z; Minthorn EA; Strum SL; Wood ER; Elkins PA; Concha NO; Heerding DA
    Bioorg Med Chem Lett; 2010 Jan; 20(2):673-8. PubMed ID: 20006497
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists.
    van Muijlwijk-Koezen JE; Timmerman H; Vollinga RC; Frijtag von Drabbe Künzel J; de Groote M; Visser S; IJzerman AP
    J Med Chem; 2001 Mar; 44(5):749-62. PubMed ID: 11262085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cephalostatin analogues--synthesis and biological activity.
    Flessner T; Jautelat R; Scholz U; Winterfeldt E
    Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.
    Toque HA; Nunes KP; Yao L; Liao JK; Webb RC; Caldwell RB; Caldwell RW
    J Sex Med; 2013 Jun; 10(6):1502-15. PubMed ID: 23566117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors.
    Li G; Hasvold LA; Tao ZF; Wang GT; Gwaltney SL; Patel J; Kovar P; Credo RB; Chen Z; Zhang H; Park C; Sham HL; Sowin T; Rosenberg SH; Lin NH
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2293-8. PubMed ID: 16446090
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structure-based optimization of novel azepane derivatives as PKB inhibitors.
    Breitenlechner CB; Wegge T; Berillon L; Graul K; Marzenell K; Friebe WG; Thomas U; Schumacher R; Huber R; Engh RA; Masjost B
    J Med Chem; 2004 Mar; 47(6):1375-90. PubMed ID: 14998327
    [TBL] [Abstract][Full Text] [Related]  

  • 52. para-Substituted 2-phenyl-3,4-dihydroquinazolin-4-ones as potent and selective tankyrase inhibitors.
    Haikarainen T; Koivunen J; Narwal M; Venkannagari H; Obaji E; Joensuu P; Pihlajaniemi T; Lehtiö L
    ChemMedChem; 2013 Dec; 8(12):1978-85. PubMed ID: 24130191
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potent and selective inhibitors of human immunodeficiency virus protease structurally related to L-694,746.
    Franchetti P; Perlini P; Abu Sheikha G; Cappellacci L; Grifantini M; Loi AG; De Montis A; Pani A; Marongiu ME; La Colla P
    Antivir Chem Chemother; 1998 Jul; 9(4):303-9. PubMed ID: 9875409
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 9-[(Phosphonoalkyl)benzyl]guanines. Multisubstrate analogue inhibitors of human erythrocyte purine nucleoside phosphorylase.
    Kelley JL; Linn JA; McLean EW; Tuttle JV
    J Med Chem; 1993 Oct; 36(22):3455-63. PubMed ID: 8230137
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of Rho kinase protects against colitis in mice by attenuating intestinal epithelial barrier dysfunction via MLC and the NF-κB pathway.
    Zou Y; Ma L; Zhao Y; Zhang S; Zhou C; Cai Y
    Int J Mol Med; 2018 Jan; 41(1):430-438. PubMed ID: 29115372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kamolonol suppresses angiotensin II-induced stress fiber formation and cellular hypertrophy through inhibition of Rho-associated kinase 2 activity.
    Kim MS; Oh KS; Lee JH; Ryu SY; Mun J; Lee BH
    Biochem Biophys Res Commun; 2013 Aug; 438(2):318-23. PubMed ID: 23891689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and Properties of 1,3-Disubstituted Ureas Containing (Adamantan-1-yl)(phenyl)methyl Fragment Based on One-Pot Direct Adamantane Moiety Inclusion.
    D'yachenko V; Danilov D; Kuznetsov Y; Moiseev S; Mokhov V; Burmistrov V; Butov G
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structure-activity analysis of vinylogous urea inhibitors of human immunodeficiency virus-encoded ribonuclease H.
    Chung S; Wendeler M; Rausch JW; Beilhartz G; Gotte M; O'Keefe BR; Bermingham A; Beutler JA; Liu S; Zhuang X; Le Grice SF
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3913-21. PubMed ID: 20547794
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tyrosine kinase inhibitors. 12. Synthesis and structure-activity relationships for 6-substituted 4-(phenylamino)pyrimido[5,4-d]pyrimidines designed as inhibitors of the epidermal growth factor receptor.
    Rewcastle GW; Bridges AJ; Fry DW; Rubin JR; Denny WA
    J Med Chem; 1997 Jun; 40(12):1820-6. PubMed ID: 9191958
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclohexylcarbamic acid 3'- or 4'-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.
    Mor M; Rivara S; Lodola A; Plazzi PV; Tarzia G; Duranti A; Tontini A; Piersanti G; Kathuria S; Piomelli D
    J Med Chem; 2004 Oct; 47(21):4998-5008. PubMed ID: 15456244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.